Brief: India's GlaxoSmithKline Pharma To Sell Vemgal Manufacturing Site
28/10/2020 13:56
Oct 28 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* TO SELL VEMGAL MANUFACTURING SITE
Source text for Eikon: ID:nBSE7ZTn8V
Further company coverage: GLAX.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees